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ROBERT A. KLONER, MD, PHD, FACC 
Boston, Massachusetts 
Prolonged postischemic ventricular dysfunction ("stunned 
myocardium") may be responsible for heart failure after 
myocardial reperfusion. Although inotropic stimulation 
can enhance the contractility of stunned myocardium, 
it could potentially increase infarct size and thereby im•
pair ultimate recovery of myocardial function. In 16 
anesthetized dogs, the left anterior descending coronary 
artery was occluded for 2 hours, and then reperfused. 
At 45 minutes of reperfusion, the dogs were randomized 
to receive a 3 hour intravenous infusion of either saline 
solution or dopamine (10 ltg/kg per min), and 1 hour 
after the infusion was discontinued the area of necrosis 
and an in vivo area at risk of necrosis were determined. 
All dogs had serial two-dimensional echocardiograms 
with computer-assisted analysis and in vivo biopsies for 
determination of adenosine triphosphate and creatine 
phosphate levels. 
Dopamine caused an increase in the contractility of 
the reperfused myocardium, with systolic wall thick•
ening increasing from - 4.1 ± 2.6 (mean ± SEM) to 
+ 24.0 ± 3.7% (p < 0.002) and short-axis cross-sec•
tional ejection fraction increasing from 27.1 ± 4.7 to 
71.6 ± 4.4% (p < 0.002) after 15 minutes of infusion. 
Reperfusion of ischemic myocardium, if initiated early after 
the ischemic insult, has been demonstrated to reduce infarct 
size (1-4). However, reperfusion does not benefit cardiac 
function immediately; instead, function improves gradually 
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Regional myocardial blood flow in the previously isch•
emic epicardium was increased from 1.18 ± 0.11 ml/min 
per g with saline to 2.95 ± 0.36 ml/min per g with 
dopamine (p < 0.03). One hour after discontinuing the 
infusion, there were no significant differences between 
the dopamine-treated and saline-treated groups in the 
area of necrosis, expressed as a percent of the area at 
risk (31.1 ± 7.2% dopamine versus 35.8 ± 5.6% sa•
line), in the systolic wall thickening (-9.5 ± 1.4% do•
pamine versus - 10.4 ± 3.0% saline), or in the short•
axis cross-sectional ejection fraction (10.0 ± 2.8% do•
pamine versus 15.1 ± 3.9% saline). Similarly, there 
were no differences between the two groups in either 
endocardial or epicardial adenosine triphosphate or 
creatine phosphate concentrations. Thus, prolonged ino•
tropic stimulation with dopamine for 3 hours augmented 
contractility of reperfused canine myocardium, but did 
not cause a deterioration in myocardial function, a re•
duction of myocardial high energy phosphate stores or 
an increase in infarct size 1 hour after cessation of do•
pamine infusion. 
(J Am Coil CardioI1985;6:1026-34) 
over days or even weeks (5-8). This prolonged, postisch•
ernie ventricular dysfunction has been termed "stunned 
myocardium" (9). It is now possible, in patients with acute 
myocardial infarction due to coronary thrombosis, to induce 
rapid thrombolysis in an occluded coronary artery with re•
sultant reperfusion and salvage of jeopardized ischemic 
myocardium (10-14). Stunning of the myocardium is also 
observed in the clinical setting, because there is usually no 
immediate change in left ventricular function after throm•
bolysis, although improvement may be seen I to 3 weeks 
later (11, IS). 
Since failure of the myocardial pump with resultant pul•
monary edema or cardiogenic shock is a major problem in 
patients hospitalized with acute myocardial infarction (16), 
some patients treated successfully with reperfusion of the 
occluded coronary artery will require positive inotropic sup•
port. Although inotropic agents may have a deleterious ef-
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fect on ischemic myocardium, extending the area of isch•
emic injury (17), they can increase the contractility of the 
stunned myocardium at least transiently (IS.19). However, 
it is possible that with its attendant increase in myocardial 
oxygen demands, inotropic stimulation of myocardium dis•
playing postischemic depression of left ventricular function 
could cause further ischemic damage of the salvaged myo•
cardium, resulting in a further deterioration of function, 
depression of high energy phosphate stores and necrosis of 
the previously ischemic myocardium. 
This study was designed to investigate the effects of a 
commonly used inotropic agent. dopamine, on reperfused 
canine myocardium. In particular, we studied the effect of 
dopamine on regional myocardial blood flow, high energy 
phosphate stores and myocardial function both during the 
infusion and during recovery I hour after infusion and on 
the ultimate size of the infarct. 
Methods 
Animal preparation. Twenty-four mongrel dogs of either 
sex (weight 20 to 40 kg) were anesthetized with sodium 
pentobarbital (30 mg/kg body weight), intubated and ven•
tilated with room air using a Harvard respirator. Additional 
sodium pentobarbital was administered. as required, 
throughout the remainder of the experiment to maintain 
adequate anesthesia. Cannulas were inserted into the left 
common carotid artery for continuous measurement of ar•
terial pressure and withdrawal of blood samples during mea•
surement of regional myocardial blood flow, and into the 
left jugular vein for administration of intravenous fluid and 
drugs. The chest was opened through a left thoracotomy 
and the heart exposed in a pericardial cradle. A cannula was 
inserted into the left atrium for the injection of microspheres 
to measure regional myocardial blood flow. A Millar mi•
cromanometer tip catheter, placed into the left ventricle 
through the left atrium, recorded left ventricular end-dia•
stolic pressure. The left anterior descending coronary artery 
was isolated within 2 cm of its origin. 
Animals used in this study were maintained in accordance 
with the guidelines of the Committee on Animals of the 
Harvard Medical School and those prepared by the Com•
mittee on Care and Use of Laboratory Animals of the In•
stitute of Laboratory Animals Resources, National Research 
Council (DHEW Publication No. [N1HJ78-23, revised 1978). 
Protocol. After an intravenous bolus injection of lido•
caine (1.5 mg/kg) the coronary artery was occluded for 2 
hours using an atraumatic Schwartz vascular clamp. The 
clamp was then abruptly released. allowing reperfusion of 
the coronary vascular bed. After 45 minutes of reperfusion, 
the dogs were randomly allocated to receive a 3 hour in•
travenous infusion of either dopamine (\0 j.tg/kg per min) 
or an equal volume (30.6 mllh) of isotonic saline solution. 
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One hour after this infusion was discontinued, the coronary 
artery was temporarily reoccluded and phthalo blue pigment 
(Dupont) (I mg/kg) was injected into the left atrial cannula 
for determination of the in vivo area at risk of necrosis. The 
dogs then received additional pentobarbital and the heart 
was removed from the chest, dissected free of surrounding 
tissue and its surface sprayed with liquid Freon, which al•
lowed even sectioning into 4 to 5 mm transverse slices. The 
area unstained by phthalo blue pigment was measured by 
planimetry. and represented the in vivo area at risk of ne•
crosis. The slices were then incubated in triphenyltetrazo•
lium chloride for 10 minutes and washed in formalin; all 
unstained areas were measured carefully by planimetry, and 
the value was considered to represent the area of necrosis 
(20). The heart slices were weighed, and approximately I 
g samples of myocardium were cut from the epicardial, mid 
and endocardial regions, in the center of the necrotic and 
nonischemic areas, for determination of regional myocardial 
blood flow. 
Hemodynamics and myocardial blood flow. Heart rate, 
systolic and diastolic arterial pressures and left ventricular 
end-diastolic pressure were recorded at baseline (before in•
jection of lidocaine), after 30 minutes of occlusion, after 
20 minutes of reperfusion. after 15 minutes and 3 hours of 
infusion and 60 minutes after the infusion was stopped. 
RegiQnal myocardial blood flow was determined at 25 min•
utes of reperfusion and at 60 minutes of infusion by the 
injection of radioactive microspheres (scandium-46, tin-I 13) 
as described by Domenech et al. (21). 
Echocardiographic analysis. Two-dimensional echo•
cardiograms were recorded at baseline (before injection of 
lidocaine), after \05 minutes of occlusion, after 20 minutes 
of reperfusion, after 15 minutes and 3 hours of infusion and 
60 minutes after the infusion was stopped. The echocardio•
grams were obtained in the short-axis view, at the level of 
mid to lower papillary muscle. using an ATL model 850A 
scanner with a 3.0 MHz transducer. Images were recorded 
on lYC video cassettes using a Panasonic NC-S200 re•
corder. A saline-filled glove was placed on the surface of 
the heart to position the epicardium within the focal zone 
of the transducer (8). A typical echocardiogram recorded 
during occlusion, with computer analysis. is shown in Fig•
ure I. Using stop-frame analysis, end-diastolic (onset of Q 
wave in lead II) and enc!-systolic (peak ofT wave) epicardial 
and endocardial contours were traced onto acetate sheets 
and transferred by means of Summagraphics Super Grid 
System to a Y AX computer with Tektronix 4014 terminal 
display. Four consecutive regular cardiac cycles were ana•
lyzed and averaged for each time point. End-systolic and 
end-diastolic wall thicknesses were determined at 2° inter•
vals with a radial contraction model using the endocardial 
end-diastolic center of mass as the center point, and the 
epicardial center of mass and midseptal point to align the 
end-diastolic and end-systolic contours and to define the 0° 
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Figure 1. Two-dimensional echocardiogram in end-systole during 
coronary occlusion showing short-axis section at the level of the 
papillary muscles. The area which thins during systole is marked 
by arrowheads. Saline-filled glove (S) and right ventricle (rv) are 
indicated. Corresponding computer analysis of percent septal wall 
thinning for four consecutive cardiac cycles is shown below. Mea•
surements begin at the midseptal point (00 ). The central 45" of 
ischemia is marked between the first (F) and last (L) degrees of 
that octant, with the mean numerical value shown above. 
reference point (8). The segment of myocardial wall that 
thinned during systole was calculated from the computer 
printout (Fig. I). The central 45° of ischemia was calculated 
as the central 45° of the myocardial wall segment that ex•
hibited systolic thinning during coronary occl4sion. 
Percent systolic wall thickening in the central 45° of 
ischemia was calculated as 
(End-systolic wall thickness 
- End-diastolic wall thickness) X 100 
End-diastolic wall thickness 
Short-axis ejection fraction was calculated from the cross•
sectional areas of the entire chamber as 
(End-diastolic area - End-systolic area) X 100 
End-diastolic area 
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Biochemical analysis. In vivo myocardial biopsy spec•
imens were obtained at 30 minutes of reperfusion, 3 hours 
of infusion and 60 minutes after the infusion was stopped, 
from the center of the ischemic area and from non ischemic 
myocardium, using a disposable biopsy needle (Tru-Cut, 
Travenol). The specimens were rinsed immediately with 
iced saline solution, frozen within 5 seconds by immersion 
in liquid Freon, diVided into endocardial and epicardial halves, 
and stored at -70°C until analysis. Adenosine triphosphate 
(ATP) and creatine phosphate were determined ftuorimetr•
ically (22) and are expressed as nanomoles per milligram 
cardiac protein. 
Statistical analysis. Comparisons were performed be•
tween two means using Student's t test, and between mul•
tiple means using analysis of vatiance for repeated mea•
surements. Bonferroni's correction was used to determine 
the level of statistical significance (23). All values are ex•
pressed as mean ± standard error of the mean. 
Results 
Three dogs died with ventricular fibrillation within 10 
minutes of occluding the left anterior descending coronary 
artery. Two additional dogs died approximately 90 minutes 
after occlusion, and three clogs were excluded because of 
recurrent ventricular fibrillation during occlusion and re•
perfusion prior to randomization. Sixteen dogs completed 
the study, of which eight received dopamine and eight re•
ceived saline infusion. 
Hemodynamics (Fig. 2.). Dopamine significantly in•
creased heart rate and systolic and diastolic arterial pressures 
throughout the infusion, but left ventricular end-diastolic 
pressure was elevat~d only at 15 minutes. The product of 
systolic pressure and heart rate (rate-pressure product) was 
increased from 18,750 ± 1,947 mm Hg . beats/min at 20 
minutes reperfusion to 35,882 ± 2,471 mm Hg . beats/min 
at 15 miniItes of dopamine infusion (p < 0.002). At 1 hour 
postinftision, heart rate, blood pressure and the rate-pressure 
product were not different from values in the saline group. 
Myocardial function (Table 1, Fig. 3). In the dogs that 
were to receive a saline infusion, short-axis cross-sectional 
ejection fraction during coronary occlusion decreased from 
51.8 ± 2.9 to 10.3 ± 4.0% (Fig. 3A), with 181.0 ± 9.7° 
of the wall circumference thinned during systole (Fig. 38); 
in the central 45° of ischemia, systolic wall thickening de•
creased from 38.2 ± 5.4 to - 15.4 ± 1.3% (Fig. 3C). 
After 20 minutes of reperfusion, cross-sectional ejection 
fraction had Increased to 31.4 ± 3.9%, wall thinning during 
systole had decreased to 68.5 ± 25.2° and systolic wall 
thickening in the central 45° of ischemia had increased to 
- 0.6 ± 2.1 %. There were no significant differences be•
tween these results and those for the dogs that were to 
receive a dopamine infusion. In the saline group, the early 
improvement in function at 20 minutes of reperfusion was 
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Figure 2. Heart rate, systolic (triangles) and diastolic (squares) 
blood pressures and left ventricular end-diastolic pressures (L VEDP) 
are shown dljring preocclusion (Pre) and at 30 minutes of occlusion 
(Occl), 20 minutes of reperfusion (Rep), 15 minutes and 3 hours 
of infusion (1-15 min, I-3h) and I hour postinfusion (Post-I). Sa•
line-treated dogs are shown as open symbols and dopamine-treated 
dogs 'IS closed symbols. Each point represents the mean of eight 
observations, except where otherwise indicated for left ventricular 
end-diastolic pressure with corresponding error bars. * p < 0.05 
verSlIS saline; **p < 0.001 versus saline. 
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not sustained over 5 hours, with a decrease in cross-sectional 
ejection fraction to 15, I ± 3,9%, an increase in degrees 
of systolic wall thinning to 128,3 ± 16.4° and a decrease 
in systolic wall thickening in the central 45° of ischemia to 
- 10.4 ± 3,0%, 
After 15 minutes of infusion, dopamine, compared with 
saline, had significantly increased cross-sectional ejection 
fraction to 71.6 ± 4.4% (p < 0,002) (Fig, 3A), with no 
segment of systolic wall thinning (p < 0,002) and an in•
crease in systolic wall thickening in the central 45° of isch•
emia to 24,0 ± 3,7% (p < 0,002), At 3 hours, the changes 
induced by dopamine tended to be of lesser degree than 
those at 15 minutes, though values were still significantly 
greater than at pre infusion , One hour after dopamine was 
discontinued, function had declined to levels similar to those 
observed in the saline control group (Fig, 3), 
Myocardial blood flow (Table 2). Regional myocardial 
blood flow showed some variability among individual dogs, 
However, there was no difference between the saline- anq 
dopamine-treated groups in either the previously ischemic 
or nonischemic regions when the measurements were made 
at 25 minutes of reperfusion, that is, before dopamine in•
fusion, After I hour of dopamine infusion, blood flow to 
the epicardial region of reperfused myocardium was sig•
nificantly increased and there was an approximate doubling 
of blood flow to all regions in the nonischemic myocardium, 
Blood flow to the previously ischemic endocardium and 
midmyocardium was increased with dopamine, though this 
did not reach statistical significance, perhaps because of 
some vascular damage, as occurs with the "no-reflow" 
phenomenon (24), or because of an attenuated demand re•
sulting from less viable contracting muscle in these regions, 
Table 1. Echocardiographic Results for Percent Systolic Wall Thickness, Degrees of Systolic Wall Thinning and Short-Axis Cross-
Sectional Ejection Fraction 
Systolic Wall Thickness 
Systolic Wall ThinningO 
Short-Axis Cross-Sectional Ejection 
(%) Fraction 
Rep 20 min [-15 min Post-I 
Rep 20 
[-15 min Post-[ 
Rep 20 
1-15 min Post-[ 
min min 
SAL DA SAL DA SAL DA SAL DA SAL DA SAL DA SAL DA SAL DA SAL DA 
- 3.5 4.7 -11.4 14.0 -15.2 - 8.8 62 38 126 0 166 140 41 40 22 65 6 19 
8.6 -4.1 2.2 19.6 3.8 - 3.7 0 lIS 20 0 78 138 46 7 40 67 36 2 
- 5.3 3.4 - 4.9 27.4 1.6 -12.1 134 42 80 0 42 160 39 43 24 85 14 2 
- 3.9 -3.6 - 4.6 12.7 -11.2 -15.8 186 114 176 0 162 184 18 9 19 69 15 18 
2.6 6.1 - 8.3 45.3 -13.9 - 6.7 44 4 146 0 146 136 17 54 9 84 0 7 
4.0 3.6 I.7 21.5 -14.4 - 7.4 0 46 38 0 150 158 36 8 37 56 II 8 
- 10.0 1.3 -14.3 30.0 -20.9 -13.4 122 26 154 0 168 118 22 32 18 88 16 21 
2.4 -5.9 6.8 21.4 -12.6 - 8.4 0 78 0 0 114 174 33 27 48 60 24 4 
Mean -0.6 0.7 -4.1 24.0 - 10.4 -9.5 69 58 93 0 128 151 31 28 27 72 15 10 
±SEM 2.1 1.6 2.6 3.7 3.0 1.4 25 15 24 0 16 8 4 6 5 4 4 3 
p 
NS < 0.002 NS NS < 0.002 NS NS < 0.002 NS 
DA = dopamine; [-15 min = 15 minutes of infusion; Post-I = I hour postinfusion; Rep 20 min = 20 minutes of reperfusion; SAL = saline. 
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Figure 3. Myocardial function during preocclusion (Pre), and at 
15 minutes before release of occlusion (Occl), 20 minutes of re•
perfusion (Rep), 15 minutes and 3 hours of infusion (I-IS mih, 1-
3h) and I hour postinfusion (Post-I). A, Percent change in left 
ventricular short-axis cross-sectional area (%6 AREA); B, number 
of arc degrees of systolic wall thinning ("THIN); C, percent change 
in systolic wall thickening (%SWT) in central 45° of ischemic 
myocardium. 0 = saline treated; • = dopamine-treated; * p < 
0.002 versus saline. 
Table 2. Regional Myocardial Blood Flow (mllmin per g) 
Previously Ischemic 
SAL DA 
Reperfusion 
Endo 1.98 ± 0.44 1.80 ± 0.36 (8) 
Mid 1.52 ± 0.32 1.73 ± 0.17 (8) 
Epi 1.31 ± 0.16 1.97 ± 0.28 (8) 
Infusion 
Endo 1.28 ± 0.30 1.72 ± 0.40 (7) 
Mid 0.82 ± 0.17 1.88 ± 0.31 (7) 
Epi 1.18 ± 0.11 2.95 ± 0.36 (7) 
p 
NS 
NS 
NS 
NS 
NS 
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Area of necrosis (Table 3). There were no significant 
differences between the saline- and dopamine-treated groups 
in the area at risk of necrosis and in the area of necrosis 
expressed as a percent of either the total left ventricle or of 
the area at risk; the latter was 35.8 ± 5.6% in the saline•
treated control dogs and 31. 1 ± 7.2% in the dopamine•
treated dogs. 
High energy phosphates (Table 4). During reperfusion 
in the saline-treated group, ATP concentrations in the non•
ischemic endocardium and epicardium were 37.3 ± 1.3 and 
35.4 ± 1.6 nmol/mg protein, respectively, but in the pre•
viously ischemic endocardium and epicardium the levels 
were reduced to 7.6 ± 2.0 and 14.5 ± 1.6 nmol/mg protein, 
respectively (p < 0.002). These levels did not recover sig•
nificantly during or up to 1 hour after saline infusion. In 
the dopamine-treated group, ATP levels were not signifi•
cantly different from those in the saline group during re•
perfusion or dopamine infusion or at 1 hour after cessation 
of the infusion. 
In the saline group, creatine phosphate concentrations in 
the nonischemic endocardium and epicardium after 30 min•
utes of reperfusion were 50.1 ± 3.9 and 52.8 ± 3.9 nmol/mg 
protein, respectively. At this time, compared with myocar•
dium that had never been ischemic, creatine phosphate lev•
els ih the previously ischemic myocardium were reduced in 
the endocardium (15.4 ± 2.5 nmol/mg protein, p < 0.003) 
but not in the epicardium (48.2 ± 8.1 nmol/mg protein, 
p > 0.05). One hour after cessation of the saline infusion, 
that is, after 4% hours of reperfusioh, creatine phosphate 
levels in the endocardium had not changed significantly 
(p = 0.22) but had increased in the epicardium to 69.7 ± 
9.4 nmol/mg protein (p < 0.04 versus 30 minutes of re•
perfusion). Individual variation was noted among the dogs. 
At 20 minutes of reperfusion creatine phosphate levels in 
the endocardium appeared lower in the saline group, while 
during infusion and at 1 hour postinfusion, these levels in 
both the endocardium and the epicardium appeared lower 
in the dopamine group. However, no significant differences 
were seen between the dopamine and the saline groups at 
any of the measured time points. 
Nonischemic 
SAL DA p 
1.27 ± 0.22 1.67 ± 0.15 (8) NS 
1.48 ± 0.18 1.66 ± 0.17 (8) NS 
1.49 ± 0.26 1.81 ± 0,18 (8) NS 
1.20 ± 0.14 3.40 ± 0.50 (7) < 0.05 
1.40 ± 0.20 3.41 ± 0.42 (7) < 0.008 
< 0.03 1.34 ± 0.14 3.19 ± 0.49 (7) NS 
Results are given as mean ± SEM; number of observations in parentheses. Endo = endocardium; Epi = epicardium; Mid = midmyocardium; other 
abbreviations as in Table 1. 
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Table 3. Area at Risk of Necrosis and Area of Necrosis Expressed as a Percent of the Left Ventricle, and Area of Necrosis 
Expressed as a Percent of Area at Risk of Necrosis 
AR/LV (%) AN/LV (%) AN/AR (%) 
SAL DA SAL DA SAL DA 
18.6 30.4 7.3 17.3 39.4 57.1 
25.6 25.6 9.3 9.0 36.3 35.3 
32.4 25.0 15.5 4.3 47.7 17.1 
26.9 31.2 12.4 18.6 46.2 59.8 
23.0 22.0 4.9 0.9 21.1 4.2 
28.9 29.6 17.2 11.5 59.7 38.9 
29.5 26.7 7.2 6.7 24.3 24.9 
20.7 13.0 2.4 1.5 11.4 11.6 
Mean 25.7 25.4 9.5 8.7 35.8 31.1 
±SEM 1.7 2.1 1.8 2.4 5.6 7.2 
P NS NS NS 
AN = area of necrosis; AR = area at risk of necrosis; LV = left ventricle; other abbreviations as in Table I. 
Thus, I hour after cessation of the infusion. ATP and 
creatine phosphate levels of the reperfused myocardium were 
not reduced in the dopamine-treated group in either the 
endocardial half, which tended to contain necrotic myocar•
dium. or the epicardial half, which tended to contain non•
necrotic myocardium and could respond to dopamine 
stimulation, 
Discussion 
The fate of ischemic myocardium is determined by the 
balance between myocardial oxygen supply and demand 
(25,26). While the oxygen supply remains reduced. there 
may be progressive cell death as a function of the duration 
of the ischemic insult (2,3). Although reestablishing myo•
cardial oxygen supply by coronary reperfusion will reduce 
the extent of myocardial necrosis depending on the duration 
and severity of the ischemic insult (27), the recovery of 
myocardial function may be substantially delayed (8.11 ,28). 
Recent studies, however, have demonstrated that reper•
fused. poorly contracting myocardial cells will respond. at 
least briefly. to inotropic stimulation with dopamine (18.19), 
although it has not been determined whether continued stim•
ulation will maintain contractility. deplete energy stores and 
accelerate necrosis of these previously ischemic poorly con•
tracting myocytes. Some evidence suggests that 30 minute 
infusions of isoproterenol and dobutamine. when adminis•
tered to previously ischemic reperfused myocardium in an 
isolated rat heart model (29). do not induce further tissue 
damage. 
Effects of dopamine stimulation on reperfused isch•
emic myocardium. The results of the present study demon•
strate that previously ischemic reperfused myocardium can 
be stimulated with intravenous dopamine to contract actively 
for up to 3 hours. Furthermore, I hour after cessation of 
the infusion. when compared with values in the saline-treated 
control group, the function of the reperfused myocardium 
was not depressed. there was no depletion of high energy 
phosphate stores. and the extent of myocardial necrosis was 
not increased. Therefore. while dopamine can stimulate the 
function of the stunned myocardium. this stimulation for 3 
hours does not appear to be harmful. These findings are of 
Table 4. Intramyocardial Adenosine Triphosphate and Creatine Phosphate Concentration (nmollmg cardiac protein) in the 
Endocardium and Epicardium of Nonischemic Myocardium and in Previously Ischemic Myocardium at 30 Minutes of Reperfusion. 
3 Hours of Infusion and I Hour Postinfusion 
Nonischemic Reperfusion Infusion Postinfusion 
Endo Epi Endo Epi Endo Epi Endo Epi 
ATP 
SAL 37.3 ± 1.3 35.4 ± 1.6 7.6 ± 2.0 14.5 ± 1.6 6.2 ± 2.1 16.1 ± 2.8 6.7 ± 1.7 16,2 ± 2.2 
DA 34.0 ± 2.2 33.8 ± 1.7 8.7 ± 2.3 13.1 ± 3.1 5.5 ± 1.8 14.6 ± 2.7 6.7 ± 1.7 15.3 ± 3.0 
CP 
SAL 50.1 ± 3.9 52.8 ± 3.9 15.4 ± 2.5 48.2 ± 8.1 33.7 ± 14.6 65.4 ± 8.8 37.0 ± 12.4 69.7 ± 9.4 
DA 49.2 ± 3.7 55.3 ± 2.9 32.6 ± 6.1 37.6 ± 7.8 21.7 ± 6.9 46.8 ± 7.0 30.0 ± 8.3 51.7 ± 9.5 
ATP = adenosine triphosphate; CP = creatine phosphate; other abbreviations as in Tables 1 and 2. There were no significant differences between 
saline and dopamine groups. Results are given as mean ± SEM. 
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clinical relevance because left ventricular failure in the post 
reperfusion state is not unusual, and there is reluctance to 
stimulate the contractility of the postischemic poorly con•
tracting myocardium and thereby increase its oxygen demands. 
The ability of intravenous dopamine to cause prolonged 
stimulation of the reperfused myocardium without an in•
crease in infarct size or decrease in high energy phosphate 
stores suggests that the primary cause of postischemic ven•
tricular dysfunction is not an autoregulatory mechanism of 
self-preservation, whereby the myocardium contracts weakly 
to preserve its limited energy stores. Furthermore, although 
the exact cause of postischemic ventricular dysfunction re•
mains unclear, inotropic stimulation of poorly contracting 
reperfused,myocardium does not appear to be analogous to 
"whipping a tired horse." Infarct size was not increased, 
and this was probably due to the administration of dopamine 
while the coronary bed was reperfused which allowed ox•
ygen supply to be maintained in the endocardium and mid•
myocardium, and actually increased in the epicardium as a 
result of an increase in regional myocardial blood flow. 
However, in view of its unique hemodynamic effects, it 
is not clear if these results with dopamine may be extrap•
olated to other inotropic agents. Dopamine, in addition to 
its positive inotropic properties, has positive chronotropic 
effects and differential regional vasodilator and vasocon•
strictor actions (30-34). Other inotropic agents may produce 
a different spectrum of hemodynamic effects. The dose of 
dopamine administered in the present study was chosen 
because it is similar to doses that have previously been 
shown to be effective in stimulating the reperfused myo•
cardium (18,19), and it is a dose frequently given in the 
clinical setting (35). It produced an approximate doubling 
of the rate-pressure product which, in addition to the marked 
increase in contractility (23,25) and small elevation in left 
ventricular end-diastolic pressure, would be expected to in•
crease myocardial oxygen consumption substantially. How•
ever, coronary blood flow was increased in the epicardium, 
presumably to meet this increase in oxygen demand. This 
increase in blood flow to the previously ischemic endocar•
dium and midmyocardium was not significant, but stimu•
lation with dopamine did not increase systolic wall thick•
ening in this area above preocclusion values, and perhaps 
for this reason there was no further reduction in high energy 
phosphate stores or increase in the area of necrosis. 
Regional function. With reperfusion, there was an im•
provement in pump function as reflected by the increase in 
short-axis cross-sectional ejection fraction and systolic wall 
thickening and a reduction in the extent of myocardial wall 
that thinned during systolic contraction. In the saline control 
group, these improvements gradually diminished over the 
ensuing 4 hours. Other studies from our laboratory (19) 
have previously shown that in a similar canine model with 
a 2 hour coronary occlusion followed by reperfusion, there 
is a transient but minimal recovery at I hour of reperfusion, 
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but this is diminished by 24 hours of reperfusion. After 
release of brief coronary occlusions (5 to 15 minutes) there 
is actually a period of exaggerated improvement (36), which 
may be due to a hyperemic response. The presence of a 
hyperemic response after release of the coronary occlusion 
was suggested in the present study when blood flow in the 
endocardium and midmyocardium in the saline group during 
reperfusion is compared with flow in nonischemic myocar•
dium during reperfusion and previously ischemic tissue dur•
ing infusion of saline solution (Table 1). However, the du•
ration of the hyperemic response after a 2 hour occlusion 
and its possible contribution to the initial improvement are 
not known. One hour after cessation of the infusion there 
was no difference in pump function between the saline- and 
dopamine-treated groups. This not only implies that dopa•
mine did no harm, but also suggests that, in this experi•
mental model of reperfused myocardium, dopamine did not 
result in sustained benefit after cessation of infusion, which 
is not surprising in view of the short half-life of the drug. 
The measurement of short-axis cross-sectional ejection frac•
tion was influenced by the section of wall that was not 
ischemic and could respond normally to dopamine infusion. 
The degrees of systolic wall thinning and the systolic wall 
thickening, however, reflect directly the area of myocardium 
that was ischemic and, on reperfusion, became "stunned." 
This may explain why systolic wall thickening did not reach 
preocclusion values at 15 minutes of the dopamine infusion, 
while cross-sectional ejection fraction exceeded preocclu•
sion values. 
Area at risk of necrosis and area of necrosis. A mea•
sure of the quantity of myocardium at risk of necrosis is 
important because there are differences among dogs in the 
distribution of coronary vessels and their collateral connec•
tions. Postmortem, in vitro perfusion with phthalo pigments 
or barium gels (3,37) demarcates the occluded bed size but 
does not make allowance for the blood flow contribution 
through collateral blood vessels and therefore overestimates 
the actual size of the area at risk of necrosis. In vivo injection 
of albumin microspheres (38) or phthalo blue pigment ap•
pears more physiologic, since these markers enter perfused 
areas of myocardium. In the present study, blue pigment 
was injected at the end of the experiment, I hour after 
termination of dopamine. At this time there was no hemo•
dynamic evidence that the drug was still active and, there•
fore, it would not be expected to alter blood flow distribution 
in the myocardium. The risk zones obtained by injection of 
albumin microspheres at 15 minutes of coronary occlusion 
and by dye injection after 6 hours of occlusion are highly 
comparable when measured in a similar dog model in which 
no dopamine or reperfusion is present (39). 
The measurement of area of necrosis by incubation in 
triphenyltetrazolium chloride has been established as a re•
liable method of detecting myocardial infarction, showing 
a strong correlation with histologically determined necrosis 
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(40,41). In the rat, triphenyltetrazolium chloride stammg 
can detect infarction sometimes as early as 30 minutes post•
occlusion, almost always at I hour and always at 3 hours 
(41). Triphenyltetrazolium chloride staining shows a close 
correlation with histologically determined infarct size and 
distinguished early irreversibly damaged cells as assessed 
by electron microscopy from normal cells (42). These find•
ings in the rat are consistent with those in the dog model, 
in which a close relation between triphenyltetrazolium chlo•
ride staining and electron microscopy was demonstrated 
(40). When reperfusion is performed, triphenyltetrazolium 
chloride staining can demonstrate infarction after very brief 
occlusions (43), and it has been suggested that there is 
enhanced accuracy in reperfused tissue compared with non•
perfused tissue (permanent occlusion), possibly as a result 
of substrate or enzyme washout from dead cells, or injury 
by the reflow process (44). The results in the present study 
showed that dopamine did not increase myocardial necrosis; 
this is consistent with the concurrent results of myocardial 
function and high energy phosphate content, neither of which 
was substantially worse than in the saline group. 
Limitations. This study was performed in an anesthe•
tized, open chest canine model, and extrapolations to the 
clinical management of patients should be made cautiously. 
In particular, this model allows complete reperfusion of the 
coronary artery, but in patients sUbjected to thrombolytic 
therapy alone, there is often a residual stenosis that may 
prevent the increase in myocardial blood flow seen in the 
epicardium of the previously ischemic zone during dopa•
mine stimulation. However, this probably does not apply 
to patients in whom reperfusion is carried out by means of 
angioplasty or coronary bypass grafting (alone or after 
thrombolysis). The model also produces an abrupt, complete 
occlusion to previously healthy myocardium, whereas in 
patients there may be varying degrees of ischemia with 
previously damaged myocardium. Dopamine was infused 
for 3 hours, but longer periods of stimulation could have a 
different effect. Recovery from dopamine was assessed at 
I hour after cessation of the infusion, and although the 
effects of dopamine wear off very rapidly, it is possible that 
observation for a longer period of time might uncover subtle 
differences. 
Conclusions. In this dog model, a 3 hour infusion of 
dopamine may be used to increase the contractility of re•
perfused myocardium without a resultant increase in infarct 
size, reduction in high energy phosphate stores or deterio•
ration in myocardial function when measured I hour after 
cessation of the infusion. Therefore, short-term cautious 
administration of this agent may be considered in the treat•
ment of severe cardiac failure during periods of postischemic 
ventricular dysfunction. It remains important to determine 
whether these conclusions apply in the presence of residual 
stenosis, to infusions of longer duration and to inotropic 
agents other than dopamine. 
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